Mechanism of thymic compartmentalization was studied in the transgenic system using the promoter of thymic stromal cotransporter (TSCOT), a cortical thymic epithelium-specific gene. The transgenic 3.1 kb TSCOT (3.1T) and 4.4 kb TSCOT (4.4T) promoters recapitulated the thymic organ and the cortical epithelial cell-specific expression at the newborn stage. However, the 3.1T driving enhanced green fluorescent protein (EGFP; 3.1T-EGFP) or Cre-recombinase (3.1T-CreE) redistributed the expression into the medulla at the adult stages. Two Cre-transgenic lines (3.1T-CreE and 4.4T-CreE), when crossed with the ROSA LacZ or EGFP lines, showed the reporter expression in both the cortex and the medulla. TSCOT promoter activities were also verified in the transient thymic epithelial cell (TEC) population expressing keratin 5 and keratin 8. These indicate that the TSCOT promoter is turned on in the bipotent TEC precursors and regulated in a compartment-specific, developmentally regulated fashion. These transgenic lines provide the useful systems for delineating the specific pathways for TEC lineage development and function.
INTRODUCTION
The thymus is an organ that provides a microenvironment for the continuous development of all types of T cells throughout life. In mice, thymic organogenesis begins at embryonic day 11 by forming the thymic rudiment, it continues to mature and undergoes atrophy in later life. 1, 2 Genetic programs for early thymic organogenesis have been well characterized based on studies of genetically modified mouse systems. Critical genes in this process include transcription factors such as FoxN1, Notch and Hox. 1, 3, 4 However, the understanding of the differentiation and compartmentalization process of thymic epithelial cells (TECs) and of their specific thymic functions still require more study at the molecular and cellular levels.
The mature thymus is distinctly organized into separate compartments by their location, such as subcapsule, cortex, medulla and corticomedullary junction. Each compartment displays specific functions such as positive and negative selection of thymocytes, and supports migration of thymocytes while they undergo the differentiation process.
2,4-6 The major cell type responsible for the specific functions in the thymic microenvironment is the epithelial cell. It is believed that the cortical TECs (cTEC) begin to differentiate during early fetal stages, whereas the medullary TECs (mTEC) differentiate after the mature double-positive thymocytes develop. 3, 7 It is also believed that cTECs and mTECs are developed from a single type of stem cell that expresses FoxN1, keratin 5 (K5) and keratin 8 (K8). 8 In addition, the presence of bipotent precursor TEC (pTEC) was suggested to give rise to the lineage-specific cTEC and mTEC. 1, 9 Recently, it was reported that CD205 þ TEC population contains bipotent TEC precursors. 10 The mature thymic microenvironment is established when pTEC differentiates into the separate lineages.
The initial fetal thymus does not have distinct areas, but compartmentalization proceeds during fetal life and continues until puberty. 11 In the fetal thymus, when only double-negative thymocytes are present, the medulla is not distinct, although medulla-specific AIRE þ cells can be found as early as embryonic day 12.
12 In newborn and young thymuses, medullas are located as separate islets within the cortical area and a single TEC stem cell can form these medullary islets that are present in 2-week-old animals. 13 The isolated medullas grow bigger and eventually fuse into one major medulla when it reaches puberty.
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The different TEC lineages are originally defined histologically by their locations. Later, some surface markers became useful in distinguishing the cell types in flow cytometry. For example, CDR-1 (Ly51, 6C3, aminopeptidase A) is used for cTECs, and Ulex europaeus agglutinin-1 (UEA-1) is a lectin binding to mTECs. 11 In addition, the cortex or medulla can be distinguishably stained by antibodies to specific cytokeratins: K8 for cTECs and K5 for mTECs. 14, 15 The pTECs were characterized by the coexpression of K5 and K8, and localized in corticomedullary junction of the adult thymus. However, the specific nature of pTEC is still not clear at this point.
Thymic stromal cotransporter (TSCOT/ly110/slc46A2) was isolated from fetal TECs 16 as a molecule exclusively expressed on the surface of cTEC. [17] [18] [19] TSCOT gene expression is developmentally regulated, 18 and is highest in the earliest fetal thymus and becomes lower in later developmental periods. 17 When TSCOT-expressing cTECs were tested for the ability to negatively select the developing thymocytes, 19 it was clear that they delete the antigen-specific developing thymocytes with great efficiency, and TSCOT-expressing cells not only express high levels of major histocompatibility complex II (MHCII) but also of costimulatory molecules, providing the evidence that cTECs actively participate in the negative selection and that there is no exclusive compartment for establishing self-tolerance.
Recently, we reported the compartmentalized TSCOT promoter activity using 3.1 kb (3.1T) and 9.1 kb (9.1T) promoter fragments in the transgenic systems with inducible compartment-specific TEC ablation. 20 The longer promoter (9.1T) in multiple founders showed reporter expression in the cortex similar to the expression profile of the endogenous gene. In contrast, the shorter promoter (3.1T) in multiple founders showed the expression in the medulla, suggesting that there are not only tissue-specific regulatory elements but also compartment-specific elements in the TSCOT promoter. These promoters that drive the nitroreductase gene to induce the compartment-specific TEC ablation provided evidence that early differentiation of ab-or gd-lineages of T cells are supported by the different TEC populations. This finding is in good agreement with the report of Graham Anderson's group that showed the specific involvement of TECs for gd-lineage of T cells. 12 Using the unique nature of exclusive gene expression patterns, we developed more transgenic mouse lines that can express enhanced green fluorescent protein (EGFP) or Cre-recombinase under the control of the TSCOT promoter. By comparing the direct EGFP expression and the results of Cre-mediated, turning on reporter expression during TEC differentiation, we found that the fragments of transgenic TSCOT promoter are active in the transiently appearing pTEC stages and separately segregated into different compartments. RESULTS AND DISCUSSION 3.1T shows developmentally regulated TEC compartment specificity. The 3.1T driving EGFP (3.1T-EGFP) transgenic line 21 with the construct of 3.1-kb TSCOT promoter directly linked to the EGFP gene (Figure 1a) shows the thymic specificity of expression. As shown in Figure 1b , in newborn mice, EGFP expression was detected only in the thymus, but not in any other tissue tested (data from other organs besides the spleen and the kidney are not shown). At the age of 4 days, EGFP expression was clearly seen in the individual epithelial cells everywhere in the thymic sections (Figure 1c) (Figure 1d and data not shown). In our previous report, all the founders of the 3.1T promoter showed the same tissue specificity. 20 Therefore, it is clear that the 3.1-kb TSCOT promoter is specific to TEC in a highly restricted fashion.
When EGFP expression was followed during postnatal development, an unexpected compartmentalization pattern was found (Figure 1e ). At the newborn stage when the compartments mostly consists of cTECs, EGFP expression was apparently in all thymic areas, but faded out in the cortical area while medullas were undergoing further differentiation. At the 2-week stage, the strongest signals were in the corticomedullary junction and subcapsule, and at the age of 8 weeks signals were mostly located in the medulla.
Next, stromal cells of 3.1T-EGFP thymuses were analyzed in flow cytometry ( Figure 2 ). As seen in Figure 2a , nearly all the cTEC and mTEC of newborns express EGFP with multiple peaks of mean fluorescence intensity. In contrast, the proportion of EGFP-expressing cells in the 8-week thymus reduced in cTECs (Figures 2b and d) , mTEC hi (51.5%) and mTEC lo (75.4%) (Figure 2d ). These expression profiles are consistent to those of histological analysis.
Therefore, we concluded that the 3.1-kb promoter activity is on all TECs of newborn but restricted in the medulla of adult mice. This result is consistently observed in all the other transgenic lines with the 3.1T promoter. 19 As the endogenous TSCOT and targeted LacZ in the TSCOT locus have maintained expression in the cortex without changes, this disparity strongly suggests that the sustained expression in the cTEC lineage requires specific element(s) residing outside the 3.1-kb promoter fragment.
The presence of EGFP-expressing cells in the corticomedullary junction of 2-week-old thymus (Figure 1e) suggested that the 3.1-kb TSCOT promoter might be active in the precursor population. Therefore, flow cytometric analysis was conducted to test the presence of transiently appearing TEC population of 2-week-old thymus. By comparing cell populations with the 8-week-old thymus (Figure 2 . 17 The mTEC lo population is not apparent in the 2-week-old thymus but becomes the major EGFPexpressing cells in adult thymuses. The profiles of EGFP expression in the 4-week-old thymuses are indistinguishable from those of 8-week-old thymuses (data not shown).
In conclusion, the 3.1T promoter activity is high in the trTEC population of young thymuses. The transient nature of the À PI À populations of 2-and 8-week stages were compared using MHCII and UEA-1, respectively. cTEC, mTEC hi , mTEC lo and trTEC population was defined as shown (CD45 À PI À gate), EGFP expression of each population was compared with the population of the same gates of thymic stromal cell preparation from C57BL/6. Mean fluorescence intensity for normal and transgenic data, % positive of the gates are indicated. population and the expression of both compartment-specific markers of CDR-1 and UEA-1 strongly suggested that trTEC is bipotent pTEC that give rise to the differentiated cTEC and mTEC.
Reporter crosses with 3.1T-and 4.4 kb TSCOT promoter (4.4T)-CreE show thymic specificity without compartmental bias in the ROSA reporter expression Two Cre lines with 3.1 kb and 4.4 kb TSCOT promoter fragments are generated using a bicitronic Cre and EGFP gene (Figure 3a and Supplementary Data 1 for the detailed map) . The 4.4T was chosen as it contains most of the evolutionarily conserved promoter sequences between human and mouse. 21 Without known causes, we were unable to detect significant EGFP levels by fluorescent microscopy of thymus organ or by the flow cytometry of TEC preparation even in the newborn stages (Figure 3b and data not shown). When the Cre-recombinase expression was investigated in the sections of adult 3.1T driving Cre-recombinase (3.1T-CreE) and 4.4T-CreE thymuses, Cre protein appeared in the medulla (K5 þ ) of 3.1T-CreE, while in the cortex (K8 þ ) of 4.4T-CreE (Supplementary Data 2) . These results show that the 3.1T promoter is medulla specific whereas the 4.4T promoter is cortex specific, similar to the endogenous gene and 9.1T transgenic system, 20 indicating that there are cortex-specific elements that reside between the 3.1-and 4.4-kb upstream promoter sequences.
When two 3.1T-CreE and 4.4T-CreE lines are crossed with ROSA lacZ (RL) reporter (Stop knock-in line), 3.1T-CreExRL and 4.4T-CreExRL, the thymic organ-specific LacZ expression patterns were evident in both lines (Figure 3c ). As seen in Figure 3d , lacZ expressions in adult thymuses appeared in both the cortex and the medulla, although expression levels appeared to be higher in the medulla. When parallel experiments were performed using crosses with the ROSA EGFP (RE) reporter (Stop knock-in), 3.1T-CreExRE and 4.4T-CreExRE, EGFP expression was also detected in both cTEC and mTEC (Figure 3e) . Most, if not all, of the TECs appear to express EGFP if compared with the basal levels derived from the nontransgenic TEC counterparts. From these, we concluded that Cre-mediated deletion of the stop sequence in the reporter lines occurred at the bipotent precursor stages before the specific lineages were committed.
The disparities in the expression pattern among the compartments between 3.1T-EGFP and 3.1T-CreExRE, and between Cre-expression and reporter expression in 4.4T-CreExRL or 4.4T-CreExRE are not surprising, as lacZ or EGFP reporter expression is the result of earlier and current Cre-mediated deletion. If the TSCOT promoter is active in the pTEC, all the daughter cells further differentiated into separate lineages from the pTEC will express the reporters due to Cre-mediated recombination. Therefore, we concluded that the 3.1-and 4.4-kb TSCOT promoters are active in the bipotent pTEC stage.
To verify whether EGFP-expressing cells include pTECs, histological staining with K5 and K8 was performed on 2-week-old thymuses. Both 3.1T-CreExRE and 4.4T-CreExRE contained the EGFP þ cells coexpressing K5 and K8 (Figure 3f ). EGFP expression detected by the specific antibodies was located among the cells with overlapping staining of K5 and K8 (triangle and arrows). These results clearly indicate that there are pTECs expressing Cre-driving EGFP. The Cre protein expression was also detected in the K5 þ K8 þ cells at adult stages of both Cre lines (Supplementary Data 3) . These results along with the result of Figure 2c provided the evidence that TSCOT promoter is turned on at the pTEC stage.
Lineage specificity and compartmentalization of TSCOT promoter activity A summary of the result for TSCOT promoter activities is shown as a diagram in Figure 4 . All TSCOT promoter fragments, including endogenous, 3.1T and 4.4T, are active in prelineage committed trTEC/pTEC. In more mature TEC stages after TEC development precedes to specific lineages of cTEC and mTEC, the endogenous and 4.4T promoters maintain activity in the pTEC and the cTEC lineages, and lose activity in the mTEC lineage. In contrast, the 3.1T promoter is active in pTEC, cTEC and mTEC at a young age but lose activity in more of the cTEC and in mTEC hi , but maintain activity in pTEC, and more of mTEC lo at the adult stage. On the basis of the result shown in the report, we propose that bipotent pTECs can be identified as MHCII hi UEA-1 lo CDRl lo K5 þ K8 þ .
MATERIALS AND METHODS Mouse
All mice were handled under the proper regulatory protocols under the guide for care and use of laboratory animals. The 3.1T-EGFP transgenic mouse was described. 20 For the Cre lines, the Cre gene was linked with internal ribosome entry site and EGFP cDNA, and placed after the TSCOT promoter fragments 
Flow cytometry
Thymic stromal cells were prepared as described. 18, 20 Histostaining Figure 4 . Schematic presentation of TSCOT promoter activities during TEC lineage specification and compartmentalization. The names of populations are shown in the boxes, the flow cytometry profiles are shown on the top of the boxes, the state of TSCOT promoter activities and expression of K5 and K8 are shown at the bottom or at the right side of the boxes.
